Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 03/15/22 12:00:00 on US and Canada Markets.
Filament Health (FLHLF) CEO Ben Lightburn provides a preview of their upcoming presentation at NobleCon18 NobleCon18 - Noble Capital Markets 18th Annual Small and Microcap Investor Conference - April 19-21, 2022 - Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts...
Strategic partnership with Kinross Gold. Allegiant Gold announced a financing and strategic investment by Kinross Gold Corporation (NYSE: KGC, TSX: K) which is expected to accelerate exploration and development activities at Allegiant's Eastside gold project in Nevada. Upon transaction close, ...
Vacation travelers have been kept home the past few years, and from the looks of things, if a world tour was on their bucket list, they are likely to remain frustrated. However, technology has an answer to this frustration, and a 22-year-old company has worked with its partner to develop a sol...
Ayala Is Developing Drugs To Block Activation Of The Notch Pathway. Under normal conditions, the Notch pathway provides signals that regulate cell growth and maintenance. Mutations in the Notch pathway can lead to loss of regulation and proliferation of cancerous cells. Ayala has developed dru...
Well Positioned for 2022. ISG posted record performance in 2021 and is well positioned for a continuation into 2022, in our view. The ISG NEXT model is growing revenue, clients, and higher profitability and trends continue to move in ISG's favor as companies adapt to all things digital. Russia...
Russia Exposure. Given the recent Russia/Ukraine events, we reviewed Kelly's direct exposure to the two countries. In 2021, Russia accounted for $132.2 million, or approximately 2.7%, of Kelly's overall revenue. As of January 2, 2022, Kelly’s Russian operations comprised approximately 1...
Price Decline is Not Supported. VEC shares continued to drop, closing on Friday at $34.48, now down $11.81, or 25.5% from the March 4th closing price, prior to the Vertex deal being announced Monday the 7th before the market opened. The sell off is unwarranted in our view. As we mentioned in o...
2Q22 Results. Revenue of $120.4 million, down 25.4% y-o-y, but was up 3.1% sequentially. We had forecast $125 million, same as consensus. Adjusted EBITDA was $9.8 million, or an 8.1% margin, down from $18.1 million and 11.2% last year. GAAP loss was $23.5 million, or $0.89 per share versus net...
2Q22 Results. Revenue of $120.4 million, down 25.4% y-o-y, but was up 3.1% sequentially. We had forecast $125 million, same as consensus. Adjusted EBITDA was $9.8 million, or an 8.1% margin, down from $18.1 million and 11.2% last year. GAAP loss was $23.5 million, or $0.89 per share versus net...
Fourth quarter and full year 2021 results. Endeavour reported adjusted fourth quarter and full year 2021 losses per share of $(0.00) and ($0.05) per share, respectively, compared to fourth quarter and full year 2020 EPS of $0.13 and $0.01. We had forecast fourth quarter earnings of $0.03 per s...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
100.0%Change Percent:
Dollarama Inc Company Name:
DLMAF Stock Symbol:
OTCMKTS Market:
dollarama.com Website: